Last checked at 15 Feb 2021 12:23
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 12 February 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
2,101,689 | 1.63% | 609,883 | 0.47% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
273,127 | 0.21% | 318,405 | 0.25% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,000 | 0.00% | 6,000 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
2,380,816 | 1.85% | 934,288 | 0.72% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 226.6900 USD |
Purchase | 1 | 226.5500 USD |
Purchase | 4 | 227.3987 USD |
Purchase | 5 | 228.1100 USD |
Purchase | 5 | 228.1200 USD |
Purchase | 8 | 226.5100 USD |
Purchase | 8 | 226.4400 USD |
Purchase | 8 | 227.4500 USD |
Purchase | 8 | 227.4050 USD |
Purchase | 8 | 227.2900 USD |
Purchase | 16 | 226.9250 USD |
Purchase | 30 | 229.3800 USD |
Purchase | 32 | 226.9100 USD |
Purchase | 39 | 227.9140 USD |
Purchase | 100 | 226.2000 USD |
Purchase | 100 | 226.4900 USD |
Purchase | 100 | 226.8300 USD |
Purchase | 100 | 227.0400 USD |
Purchase | 100 | 229.6710 USD |
Purchase | 131 | 229.6119 USD |
Purchase | 142 | 226.9409 USD |
Purchase | 418 | 229.7954 USD |
Purchase | 933 | 227.8866 USD |
Purchase | 1,300 | 227.0538 USD |
Purchase | 2,857 | 227.7870 USD |
Purchase | 2,890 | 227.4841 USD |
Purchase | 2,909 | 229.2076 USD |
Purchase | 3,014 | 227.4200 USD |
Purchase | 3,385 | 227.4608 USD |
Purchase | 6,542 | 226.9812 USD |
Purchase | 60,004 | 227.9222 USD |
Sale | 6 | 226.3900 USD |
Sale | 8 | 227.4500 USD |
Sale | 10 | 227.8000 USD |
Sale | 10 | 228.1100 USD |
Sale | 13 | 227.9969 USD |
Sale | 20 | 229.3800 USD |
Sale | 26 | 227.9140 USD |
Sale | 100 | 226.4400 USD |
Sale | 100 | 227.1400 USD |
Sale | 100 | 229.6710 USD |
Sale | 100 | 230.2700 USD |
Sale | 190 | 227.0441 USD |
Sale | 262 | 227.8417 USD |
Sale | 340 | 227.4301 USD |
Sale | 449 | 229.6361 USD |
Sale | 529 | 228.0614 USD |
Sale | 560 | 228.2158 USD |
Sale | 1,241 | 228.1538 USD |
Sale | 1,273 | 227.4199 USD |
Sale | 1,400 | 227.0135 USD |
Sale | 1,642 | 227.9352 USD |
Sale | 1,744 | 227.4200 USD |
Sale | 1,865 | 228.0977 USD |
Sale | 1,920 | 227.8282 USD |
Sale | 1,949 | 227.7274 USD |
Sale | 2,008 | 227.6027 USD |
Sale | 2,061 | 228.5958 USD |
Sale | 2,280 | 227.7340 USD |
Sale | 2,422 | 227.5055 USD |
Sale | 2,494 | 228.0158 USD |
Sale | 2,909 | 229.2076 USD |
Sale | 3,358 | 227.4637 USD |
Sale | 3,525 | 228.0533 USD |
Sale | 4,513 | 227.7861 USD |
Sale | 5,248 | 227.8690 USD |
Sale | 6,984 | 226.9679 USD |
Sale | 31,538 | 227.9024 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 15 Feb 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210215005192/en/
Copyright Business Wire 2021